- Home
- ATXS vs AMBC Comparison
ATXS vs AMBC Comparison
Compare ATXS & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- AMBC
- Stock Information
- Founded
- ATXS 2008
- AMBC 1991
- Country
- ATXS United States
- AMBC United States
- Employees
- ATXS N/A
- AMBC N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- AMBC Property-Casualty Insurers
- Sector
- ATXS Health Care
- AMBC Finance
- Exchange
- ATXS Nasdaq
- AMBC Nasdaq
- Market Cap
- ATXS 584.1M
- AMBC 635.7M
- IPO Year
- ATXS 2015
- AMBC 1991
- Fundamental
- Price
- ATXS $9.55
- AMBC $13.28
- Analyst Decision
- ATXS Strong Buy
- AMBC Strong Buy
- Analyst Count
- ATXS 5
- AMBC 2
- Target Price
- ATXS $28.00
- AMBC $17.00
- AVG Volume (30 Days)
- ATXS 340.4K
- AMBC 492.0K
- Earning Date
- ATXS 11-13-2024
- AMBC 11-12-2024
- Dividend Yield
- ATXS N/A
- AMBC N/A
- EPS Growth
- ATXS N/A
- AMBC N/A
- EPS
- ATXS N/A
- AMBC N/A
- Revenue
- ATXS N/A
- AMBC $398,000,000.00
- Revenue This Year
- ATXS N/A
- AMBC N/A
- Revenue Next Year
- ATXS N/A
- AMBC N/A
- P/E Ratio
- ATXS N/A
- AMBC N/A
- Revenue Growth
- ATXS N/A
- AMBC 22.46
- 52 Week Low
- ATXS $5.88
- AMBC $10.12
- 52 Week High
- ATXS $16.90
- AMBC $18.45
- Technical
- Relative Strength Index (RSI)
- ATXS 41.21
- AMBC 62.96
- Support Level
- ATXS $9.40
- AMBC $13.06
- Resistance Level
- ATXS $9.99
- AMBC $13.64
- Average True Range (ATR)
- ATXS 0.58
- AMBC 0.44
- MACD
- ATXS -0.01
- AMBC 0.03
- Stochastic Oscillator
- ATXS 9.32
- AMBC 73.72
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.